Novel Oral Poliovirus Vaccine 2 Safety Evaluation during Nationwide Supplemental Immunization Activity, Uganda, 2022

Details

• Alternative Title:
  Emerg Infect Dis
• Personal Author:
  Tobolowsky, Farrell A. ; Nsubuga, Fred ; Gilani, Zunera ; Kisakye, Annet ; Ndagije, Helen ; Kyabayinze, Daniel ; Gidudu, Jane F.
• Description:
  Given its enhanced genetic stability, novel oral poliovirus vaccine type 2 was deployed for type 2 poliovirus outbreak responses under World Health Organization Emergency Use Listing. We evaluated the safety profile of this vaccine. No safety signals were identified using a multipronged approach of passive and active surveillance.
• Subjects:
  Immunization Poliovirus Poliovirus Vaccine, Oral Vaccination
• Keywords:
  Bacteria Burkholderia Pseudomallei History Melioidosis Poliovirus Uganda Vaccines Vaccine Safety Viruses
• Source:
  Emerg Infect Dis. 2024; 30(4):775-778
• Pubmed ID:
  38526214
• Pubmed Central ID:
  PMC10977820
• Document Type:
  Journal Article
• Genre:
  Dispatch
• Place as Subject:
  Uganda
• Volume:
  30
• Issue:
  4
• Collection(s):
  Emerging Infectious Diseases
• Main Document Checksum:
  urn:sha256:2f94cb2b412c6e7f6c538607cceb570333a985b4007f593a58354a90fd7f6888
• Download URL:
  https://stacks.cdc.gov/view/cdc/152962/cdc_152962_DS1.pdf
• File Type:
  [PDF - 400.32 KB ]